Oxford BioMedica (OXBDF) Stock Price, Quote, News & History

Oxford BioMedica PLC (OXBDF) Stock Price, Quote, News & History

OXBDFOTCPK

Trade with Public

$8.17

Last update: Mar 6, 9:30 AM

Key Statistics

Open

Volume / Avg.

75.00 / 11.78K

Day Range

- - -

52 Wk Range

3.15 - 12.61

Market Cap

$987.53M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.65

Recent Oxford Biomedica PLC News

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1

CNBC Why Kohl’s Shares Are Plunging Today

Akanksha Bakshi

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.84M

Investing Cash Flow (TTM)

-1.89M

Financing Cash Flow (TTM)

-17.03M

Free Cash Flow (TTM)

-12.03M

Capital Expenditure (TTM)

-4.19M

Net Change in Cash (TTM)

-26.76M

Valuation Metrics

Enterprise Value

$1.13B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

4.22

PB Ratio (TTM)

22.69

Earnings Yield % (TTM)

-5.90%

Earnings Yield % (FWD)

-2.10%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.36

Company Debt

Total Debt

$36.81M

LT Debt

$36.81M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$570.00K

Total Cash

$53.88M

Debt to Equity

3.22

Issuance of Debt (TTM)

-$570.00K

Repayment of Debt (TTM)

-$570.00K

Key Statistics

Open

Volume / Avg.

75.00 / 11.78K

Day Range

- - -

52 Wk Range

3.15 - 12.61

Market Cap

$987.53M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.65

About

Sector

Health Care

Industry

Biotechnology

Oxford BioMedica PLC is a contract development and manufacturing organization (CDMO) focused on cell and gene therapy. The company specializes in viral vector development and manufacturing for cell and gene therapy, with expertise in lentivirus, aden...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Oxford BioMedica (OXBDF) stock?

You can purchase shares of Oxford BioMedica (OTCPK:OXBDF) through any online brokerage.

View our list of the best stock brokerages

Who are Oxford BioMedica (OXBDF) competitors?

There are no as such competitors for Oxford BioMedica.

What is the forecast, or price target, for Oxford BioMedica (OXBDF) stock?

There is no analysis for Oxford BioMedica to provide a consensus price target.

What is the current price for Oxford BioMedica (OXBDF)?

The stock price for Oxford BioMedica (OTCPK: OXBDF) is $8.17 last updated March 6, 2026 at 9:30 AM EST.

Does Oxford BioMedica (OXBDF) pay a dividend?

There are no upcoming dividends for Oxford BioMedica.

When is Oxford BioMedica (OTCPK:OXBDF) reporting earnings?

Oxford BioMedica does not have any upcoming earnings scheduled.

Is Oxford BioMedica (OXBDF) going to split?

There is no upcoming split for Oxford BioMedica.

What sector and industry does Oxford BioMedica (OXBDF) operate in?

Oxford BioMedica is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

Volume / Avg.

75.00 / 11.78K

Day Range

- - -

52 Wk Range

3.15 - 12.61

Market Cap

$987.53M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.65

Recent Oxford Biomedica PLC News

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1

CNBC Why Kohl’s Shares Are Plunging Today

Akanksha Bakshi

Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca's COVID-19 Vaccine

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-7.84M

Investing Cash Flow (TTM)

-1.89M

Financing Cash Flow (TTM)

-17.03M

Free Cash Flow (TTM)

-12.03M

Capital Expenditure (TTM)

-4.19M

Net Change in Cash (TTM)

-26.76M

Valuation Metrics

Enterprise Value

$1.13B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

4.22

PB Ratio (TTM)

22.69

Earnings Yield % (TTM)

-5.90%

Earnings Yield % (FWD)

-2.10%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.36

Company Debt

Total Debt

$36.81M

LT Debt

$36.81M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$570.00K

Total Cash

$53.88M

Debt to Equity

3.22

Issuance of Debt (TTM)

-$570.00K

Repayment of Debt (TTM)

-$570.00K

Key Statistics

Open

Volume / Avg.

75.00 / 11.78K

Day Range

- - -

52 Wk Range

3.15 - 12.61

Market Cap

$987.53M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

2.65

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Oxford BioMedica (OXBDF) stock?

You can purchase shares of Oxford BioMedica (OTCPK:OXBDF) through any online brokerage.

View our list of the best stock brokerages

Who are Oxford BioMedica (OXBDF) competitors?

There are no as such competitors for Oxford BioMedica.

What is the forecast, or price target, for Oxford BioMedica (OXBDF) stock?

There is no analysis for Oxford BioMedica to provide a consensus price target.

What is the current price for Oxford BioMedica (OXBDF)?

The stock price for Oxford BioMedica (OTCPK: OXBDF) is $8.17 last updated March 6, 2026 at 9:30 AM EST.

Does Oxford BioMedica (OXBDF) pay a dividend?

There are no upcoming dividends for Oxford BioMedica.

When is Oxford BioMedica (OTCPK:OXBDF) reporting earnings?

Oxford BioMedica does not have any upcoming earnings scheduled.

Is Oxford BioMedica (OXBDF) going to split?

There is no upcoming split for Oxford BioMedica.

What sector and industry does Oxford BioMedica (OXBDF) operate in?

Oxford BioMedica is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.